Prodrugs of fumarates and their use in treating various diseases
US-9775823-B2 · Oct 3, 2017 · US
Prodrugs of fumarates and their use in treating various diseases
US10596140B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10596140-B2 |
| Application number | US-201916524498-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 29, 2019 |
| Priority date | Mar 14, 2013 |
| Publication date | Mar 24, 2020 |
| Grant date | Mar 24, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.
First claim
Opening claim text (preview).
The invention claimed is: 1. A compound having the formula or a pharmaceutically acceptable salt thereof. 2. A pharmaceutical composition comprising the compound of claim 1 , or a pharmaceutically acceptable salt thereof. 3. A method of treating multiple sclerosis in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of the compound of claim 1 . 4. A method of treating multiple sclerosis in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a composition of claim 2 .
Assignees
Inventors
Classifications
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide · CPC title
Radicals derived from carbonic acid · CPC title
having a hydrogen atom as the second substituent in position 4 · CPC title
having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10596140B2 cover?
- The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.
- Who is the assignee on this patent?
- Alkermes Pharma Ireland Ltd
- What technology area does this patent fall under?
- Primary CPC classification C07C229/16. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).